Elevated triglycerides and risk of myocardial infarction in HIV-positive persons

Signe W Worm1, David A Kamara, Peter Reiss

  • 1Copenhagen HIV Programme, University of Copenhagen, Denmark. sww@cphiv.dk

Insights

Elevated triglyceride levels show a small, independent association with myocardial infarction (MI) risk in HIV-positive individuals. This association is reduced after accounting for cholesterol, cardiovascular disease, and HIV-related factors.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Elevated triglyceride levels are common in individuals with HIV.
  • The independent contribution of triglycerides to myocardial infarction (MI) risk in this population is not well-established.

Purpose of the Study:

  • To investigate the independent association between elevated triglyceride levels and MI risk in HIV-positive individuals.
  • To adjust for lipid profiles, cardiovascular disease (CVD) risk factors, and HIV-specific factors.

Main Methods:

  • A cohort study involving 33,308 HIV-positive individuals from 1999 to 2008.
  • Multivariable Poisson regression models were employed to assess MI incidence.
  • Adjustments were made for total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), non-lipid CVD risk factors, and HIV/treatment factors.

Main Results:

  • An unadjusted doubling of triglyceride levels was associated with a 67% increased MI risk.
  • After adjusting for TC and HDL-C, the relative risk (RR) for MI per triglyceride doubling decreased to 1.33.
  • Further adjustments for CVD risk factors and HIV-specific factors attenuated the RR to 1.11 (95% CI 1.01-1.23), indicating a marginally significant independent effect.

Conclusions:

  • Higher triglyceride levels are marginally independently associated with increased MI risk in HIV-positive persons.
  • The independent effect of triglycerides on MI risk in this population appears to be small after accounting for various confounders.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...